UV Sensor in Patients With Actinic Keratosis

Sponsor
Almirall, S.A. (Industry)
Overall Status
Active, not recruiting
CT.gov ID
NCT05481073
Collaborator
(none)
10
1
2.6
3.8

Study Details

Study Description

Brief Summary

To validate the use of Ultraviolet (UV) radiation sensor in patients with actinic keratosis, to identify barriers to its use in prospective longitudinal studies.

Condition or Disease Intervention/Treatment Phase
  • Device: UV sensor

Detailed Description

To prevent both acute and chronic damage from exposure to UV A and UV B radiation. Personal UV exposure can be assessed by portable sensors. Having an accurate awareness of one's own behavior (assessed by the accuracy of the UV sensor), can motivate and engage with skin protection.

Study Design

Study Type:
Observational
Actual Enrollment :
10 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Pilot Feasibility Study of Using UV Sensor in Patients With Actinic Keratosis
Actual Study Start Date :
Jun 13, 2022
Anticipated Primary Completion Date :
Aug 2, 2022
Anticipated Study Completion Date :
Sep 1, 2022

Outcome Measures

Primary Outcome Measures

  1. QOL UV sensor [Up to week 4]

    Questionnaire will be carried out to qualitatively evaluate different aspects of the usability of the UV device, Minimum Value 0; Maximun Value 20, where higher value is the better.

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

=65 years presenting actinic keratosis on scalp and/or face

Exclusion Criteria:

Patients who, due to health problems or lifestyle habits, do not expose themselves regularly to UV radiation (outdoor) for at least one hour a day.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Dermatology Unit (Hospital Clinic) Barcelona Spain

Sponsors and Collaborators

  • Almirall, S.A.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Almirall, S.A.
ClinicalTrials.gov Identifier:
NCT05481073
Other Study ID Numbers:
  • Usability UV sensor study
First Posted:
Aug 1, 2022
Last Update Posted:
Aug 3, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 3, 2022